Health LibraryHealth Librarybrought to you by therapy training school
 



Nutritional Science Labs/ Captiva Skincare
Nutritional Science Labs/ Captiva Skincare
Nutritional Science Labs/ Health Center for Better Living




Womens Health Problems :: IBS
Articles and advice for IBS and other womens health problems


Latest Articles
Low Bone Mineral Density Common In Children And Teenagers With Inflammatory Bowel Disease
A thesis from the University of Gothenburg (Sweden) is the first in Scandinavia to study the occurrence of low bone mineral density in children and teenagers with inflammatory bowel disease. Half of the patients in the study showed signs of low bone mineral density...
Tue, 24 Aug 2010 01:00:00 PDT

Stress Management, Diet Changes Improve Irritable Bowel Syndrome Symptoms
When persistent cramping, abdominal pain, bloating, gas, diarrhea and constipation are causing distress and frequent bathroom trips, the next stop should be a visit to the doctor. These symptoms, commonly caused by irritable bowel syndrome (IBS), often can be minimized with diet and lifestyle changes...
Mon, 23 Aug 2010 04:00:00 PDT

Proof That Irritable Bowel Syndrome Is Not In Your Head
Irritable bowel syndrome makes life miserable for those affected -- an estimated ten percent or more of the population. And what irritates many of them even more is that they often are labeled as hypochondriacs, since physical causes for irritable bowel syndrome have never been identified...
Sat, 21 Aug 2010 00:00:00 PDT

UCD Scientists Pinpoint Potential Key Regulator In Battle To Target Inflammatory Bowel Disease (IBD)
Research into inflammatory bowel disease (IBD) led by UCD Conway Institute scientists with national and international collaborators has identified a key regulator involved in maintaining the functional integrity of the gut lining...
Thu, 05 Aug 2010 04:00:00 PDT

N30 Pharma Announces FDA Approval To Initiate Phase 1 Clinical Trial For First-in-Class Drug
N30 Pharmaceuticals, LLC announced the approval of its Investigational New Drug Application for N6022 by the U.S. Food and Drug Administration. N6022, a first-in-class inhibitor of s-nitrosoglutathione reductase (GSNOR), has the potential to be an important new treatment for acute exacerbations of asthma, chronic obstructive pulmonary disease (COPD) and inflammatory bowel disease (IBD)...
Thu, 05 Aug 2010 04:00:00 PDT


Copyright © 2010 Therapy Training School | Sitemap | Designed by WebZen